www.fdanews.com/articles/132321-pearl-therapeutics-tops-3-billion-lung-drug-in-head-to-head-trial
Pearl Therapeutics Tops $3 Billion Lung Drug in Head-to-Head Trial
December 1, 2010
Pearl Therapeutics bagged a whopping $69 million venture round last month, and now it’s pretty clear why.
Xconomy
Xconomy